Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...
The Australian government is funding a wide-ranging national research programme that will give new hope and help to Aust...
Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have developed a new and precise way to t...
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...
The previous year witnessed many promising developments in the fight against rare diseases. The recent Casgevy’s F...
The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...
Cancer poses a significant challenge for the pharmaceutical industry, driving a constant search for improved oncology dr...
Lung cancer is the leading cause of cancer deaths in Hong Kong and worldwide, but there is still an unmet clinical need ...
AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing capabilities. With a n...
An international study led by the National Cancer Centre Singapore (NCCS) and Duke-NUS Medical School has effectively ta...
A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has demonstrated that commun...
Projections by the International Agency for Research on Cancer estimate 15.1 million new cases per year, until 2040. Thi...
US-based Vertex Pharmaceuticals Incorporated has announced that the Saudi Food and Drug Authority (SFDA) has g...
The Centre for Chinese Herbal Medicine Drug Development of Hong Kong Baptist University (HKBU) has develo...
Kite Pharma, a Gilead Company, is a global biopharmaceutical company specializing in cancer cell therapy As the global c...
GYSS 2024 is celebrating the values of science promoting collaboration and teamwork in Singapore from 8 to 12 January 20...
Denmark headquartered Novo Nordisk Foundation is committing up to $25 million to support the early-stage devel...
